Tag: Nordisk
Novo Nordisk trims outlook as obesity drug maker loses ground to Eli Lilly
Novo Nordisk, a leading pharmaceutical company known for its Wegovy obesity drug, has recently faced challenges in the…
Novo Nordisk and Pfizer’s bidding war for Metsera escalates despite legal threats
Novo Nordisk and Pfizer are currently engaged in a fierce bidding war over the acquisition of obesity biotech…
Eli Lilly, Novo Nordisk near deal with Trump on weight loss drug prices
The Trump administration is reportedly in the final stages of negotiations with pharmaceutical giants Eli Lilly and Novo…
Pfizer sues Metsera, Novo Nordisk over rival obesity drug bid
Pfizer Files Lawsuit Against Metsera and Novo Nordisk Over Merger Agreement In a recent development, Pfizer has taken…
Akero Therapeutics (AKRO) Jumps 16% on $5.2-Billion Novo Nordisk Merger
We have recently featured a piece titled 10 Major Players With Significant Gains; 6 Reach All-Time Highs. Among…
Why Shares in Novo Nordisk Bumped Higher Today
Novo Nordisk is significantly enhancing its footprint in the U.S. manufacturing industry with plans for facility expansion. The…
Cash pay is ‘going to constitute a major part of the Wegovy business’: Novo Nordisk CFO
Novo Nordisk (NVO) faced a setback with an earnings miss, causing a 4% drop in its stock price.…
Novo Nordisk reports second quarter earnings missing Wall Street estimates on slower GLP-1 sales
Novo Nordisk (NVO) stock took a hit in pre-market trading after the company reported a miss on both…
Novo Nordisk shares plummet as 2025 guidance is cut, overshadowing new CEO
Novo Nordisk, a major player in the pharmaceutical industry, has recently faced setbacks that have led to a…
UnitedHealth, Novo Nordisk, Covid vaccines
Good morning to all readers! One of the perks of having a library card is the ability to…
Novo Nordisk chief Jørgensen to step down
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this…
Is Novo Nordisk (NVO) the Best Stock to Buy According to Jim Simons’ Renaissance Technologies?
Jim Simons, the renowned billionaire investor and mathematician, is famously known as the "Quant King" of hedge funds…